How many stocks are there of Eisai Co?
The current number of stocks of Eisai Co is 286.8 M undefined.
Eisai Co Stocks 2024
Eisai Co Stocks
286.8 M
Ticker
4523.T
ISIN
JP3160400002
WKN
855526
In 2024, Eisai Co had 286.8 M outstanding stocks, a 0.01% change from the 286.76 M stocks in the previous year.
The Eisai Co Stocks history
| YEAR | NUMBER OF STOCKS (undefined JPY) |
|---|---|
| 2027e | 286.8 |
| 2026e | 286.8 |
| 2025e | 286.8 |
| 2024 | 286.8 |
| 2023 | 286.76 |
| 2022 | 286.73 |
| 2021 | 286.71 |
| 2020 | 286.65 |
| 2019 | 286.66 |
| 2018 | 286.48 |
| 2017 | 286.42 |
| 2016 | 286.47 |
| 2015 | 285.75 |
| 2014 | 285 |
| 2013 | 285 |
| 2012 | 285 |
| 2011 | 285 |
| 2010 | 285 |
| 2009 | 285 |
| 2008 | 284 |
| 2007 | 285 |
| 2006 | 286 |
| 2005 | 287 |
Eisai Co shares outstanding JP3160400002 · 855526
The number of shares was Eisai Co in 2023 — This indicates how many shares 286.761 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Eisai Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Eisai Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Eisai Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eisai Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 287 M Aktien |
| 2006 | 286 M Aktien |
| 2007 | 285 M Aktien |
| 2008 | 284 M Aktien |
| 2009 | 285 M Aktien |
| 2010 | 285 M Aktien |
| 2011 | 285 M Aktien |
| 2012 | 285 M Aktien |
| 2013 | 285 M Aktien |
| 2014 | 285 M Aktien |
| 2015 | 285.75 M Aktien |
| 2016 | 286.47 M Aktien |
| 2017 | 286.42 M Aktien |
| 2018 | 286.48 M Aktien |
| 2019 | 286.66 M Aktien |
| 2020 | 286.65 M Aktien |
| 2021 | 286.71 M Aktien |
| 2022 | 286.73 M Aktien |
| 2023 | 286.76 M Aktien |
| 2024 | 286.8 M Aktien |
| 2025e | 286.8 M Aktien |
| 2026e | 286.8 M Aktien |
| 2027e | 286.8 M Aktien |
Eisai Co Aktienanalyse
What does Eisai Co do?
Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Eisai Co's Shares Outstanding
Eisai Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Eisai Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Eisai Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Eisai Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Eisai Co stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Eisai Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Eisai Co evolved in recent years?
The number of shares of Eisai Co has increased by 0.01% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Eisai Co as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Eisai Co?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Eisai Co pay?
Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 3.67 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.
What is the dividend yield of Eisai Co?
The current dividend yield of Eisai Co is 3.67 %.
When does Eisai Co pay dividends?
Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Eisai Co?
Eisai Co paid dividends every year for the past 23 years.
What is the dividend of Eisai Co?
For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 3.7 %.
In which sector is Eisai Co located?
Eisai Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Eisai Co from 12/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Eisai Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Eisai Co in the year 2023?
In the year 2023, Eisai Co distributed 160 JPY as dividends.
In which currency does Eisai Co pay out the dividend?
The dividends of Eisai Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Eisai Co
Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
